Gerald Friedland

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Natural ventilation reduces high TB transmission risk in traditional homes in rural KwaZulu-Natal, South Africa
    Melissa Lygizos
    Yale University School of Medicine, AIDS Program, New Haven, CT, USA
    BMC Infect Dis 13:300. 2013
  2. pmc Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study
    Scott K Heysell
    Tugela Ferry Care and Research Collaboration, Tugela Ferry, South Africa
    BMC Infect Dis 10:344. 2010
  3. ncbi request reprint Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries
    Gerald Friedland
    AIDS Program, Yale University School of Medicine, New Haven, Connecticut 06510 2483, USA
    Clin Infect Dis 38:S421-8. 2004
  4. ncbi request reprint Tuberculosis and HIV coinfection: current state of knowledge and research priorities
    Gerald Friedland
    AIDS Program, Section of Infectious Diseases, Department of Internal Medicine and Epidemiology, Yale School of Medicine, New Haven, CT 06510, USA
    J Infect Dis 196:S1-3. 2007
  5. ncbi request reprint Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV
    Gerald Friedland
    Yale University School of Medicine AIDS Program, New Haven, CT 06510 2483, USA
    J Antimicrob Chemother 58:1299-302. 2006
  6. ncbi request reprint Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies
    Gerald Friedland
    AIDS Program, Section of Infectious Diseases, Department of Internal Medicine and Epidemiology, Yale University School of Medicine, New Haven, CT 06510, USA
    J Infect Dis 196:S114-23. 2007
  7. ncbi request reprint Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction
    Gerald Friedland
    AIDS Program, Yale School of Medicine, New Haven, Connecticut 06510, USA
    AIDS 19:1635-41. 2005
  8. ncbi request reprint HIV medication adherence. The intersection of biomedical, behavioral, and social science research and clinical practice
    Gerald H Friedland
    AIDS Program, Yale University School of Medicine, New Haven, Connecticut 06510 2483, USA
    J Acquir Immune Defic Syndr 43:S3-9. 2006
  9. ncbi request reprint A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting
    Christopher Jack
    Nelson R Mandela School of Medicine, University of Kwa Zulu Natal, Durban, South Africa
    J Acquir Immune Defic Syndr 36:929-34. 2004
  10. doi request reprint Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis
    Gerald Friedland
    AIDS Program, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA
    J Acquir Immune Defic Syndr 55:S37-42. 2010

Research Grants

Detail Information

Publications64

  1. pmc Natural ventilation reduces high TB transmission risk in traditional homes in rural KwaZulu-Natal, South Africa
    Melissa Lygizos
    Yale University School of Medicine, AIDS Program, New Haven, CT, USA
    BMC Infect Dis 13:300. 2013
    ..We evaluated air exchange and the impact of natural ventilation on estimated TB transmission risk in traditional Zulu homes in rural South Africa...
  2. pmc Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study
    Scott K Heysell
    Tugela Ferry Care and Research Collaboration, Tugela Ferry, South Africa
    BMC Infect Dis 10:344. 2010
    ..The yield of mycobacterial blood cultures for multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR-TB) among drug-resistant TB suspects has not been described...
  3. ncbi request reprint Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries
    Gerald Friedland
    AIDS Program, Yale University School of Medicine, New Haven, Connecticut 06510 2483, USA
    Clin Infect Dis 38:S421-8. 2004
    ..This strategy could address the related issues of inadequate access and infrastructure and need for enhanced adherence to medication and thereby potentially improve the outcome for both diseases...
  4. ncbi request reprint Tuberculosis and HIV coinfection: current state of knowledge and research priorities
    Gerald Friedland
    AIDS Program, Section of Infectious Diseases, Department of Internal Medicine and Epidemiology, Yale School of Medicine, New Haven, CT 06510, USA
    J Infect Dis 196:S1-3. 2007
  5. ncbi request reprint Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV
    Gerald Friedland
    Yale University School of Medicine AIDS Program, New Haven, CT 06510 2483, USA
    J Antimicrob Chemother 58:1299-302. 2006
    ....
  6. ncbi request reprint Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies
    Gerald Friedland
    AIDS Program, Section of Infectious Diseases, Department of Internal Medicine and Epidemiology, Yale University School of Medicine, New Haven, CT 06510, USA
    J Infect Dis 196:S114-23. 2007
    ..Conversely, smaller demonstration projects, even with successful outcomes, must grapple with issues related to generalization of findings, wider implementation, and scale up, to benefit larger populations of those in need...
  7. ncbi request reprint Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction
    Gerald Friedland
    AIDS Program, Yale School of Medicine, New Haven, Connecticut 06510, USA
    AIDS 19:1635-41. 2005
    ..Pharmacological interactions between antiretroviral drugs and methadone may result in opiate withdrawal or increased side effects...
  8. ncbi request reprint HIV medication adherence. The intersection of biomedical, behavioral, and social science research and clinical practice
    Gerald H Friedland
    AIDS Program, Yale University School of Medicine, New Haven, Connecticut 06510 2483, USA
    J Acquir Immune Defic Syndr 43:S3-9. 2006
    ....
  9. ncbi request reprint A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting
    Christopher Jack
    Nelson R Mandela School of Medicine, University of Kwa Zulu Natal, Durban, South Africa
    J Acquir Immune Defic Syndr 36:929-34. 2004
    ..This pilot study demonstrates that TB/DOT programs can be feasible and effective sites for HIV identification and the introduction and monitoring of a once-daily HAART regimen in resource-limited settings...
  10. doi request reprint Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis
    Gerald Friedland
    AIDS Program, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA
    J Acquir Immune Defic Syndr 55:S37-42. 2010
    ..All of these require structural changes directed at comprehensive prevention and treatment programs and increased collaboration and integration of needed services for substance abusers...
  11. doi request reprint Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study
    Neel R Gandhi
    Yale University School of Medicine, New Haven, CT, USA
    J Acquir Immune Defic Syndr 50:37-43. 2009
    ..In KwaZulu-Natal, South Africa, 80% of TB patients are HIV coinfected, with high treatment default and mortality rates. Integrating TB and HIV care may be an effective strategy for improving outcomes for both diseases...
  12. ncbi request reprint HIV drug resistance and HIV transmission risk behaviors among active injection drug users
    Michael J Kozal
    AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06510, USA
    J Acquir Immune Defic Syndr 40:106-9. 2005
    ..Strategies to reduce injection drug use risk behaviors among patients in clinical care are needed to reduce the transmission of sensitive and resistant HIV...
  13. pmc Timing of initiation of antiretroviral drugs during tuberculosis therapy
    Salim S Abdool Karim
    Centre for the AIDS Programme of Research in South Africa, University of KwaZulu Natal, Durban, South Africa
    N Engl J Med 362:697-706. 2010
    ..The optimal timing for the initiation of antiretroviral therapy in relation to tuberculosis therapy remains controversial...
  14. pmc Integration of antiretroviral therapy with tuberculosis treatment
    Salim S Abdool Karim
    Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
    N Engl J Med 365:1492-501. 2011
    ..We previously reported that integrating antiretroviral therapy (ART) with tuberculosis treatment reduces mortality. However, the timing for the initiation of ART during tuberculosis treatment remains unresolved...
  15. pmc The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial
    Kogieleum Naidoo
    Doris Duke Medical Research Institute, 2nd Floor, University of KwaZulu Natal, 719 Umbilo Road, Private Bag X7, Congella, 4013, Durban, South Africa
    Ann Intern Med 157:313-24. 2012
    ..Concerns about the immune reconstitution inflammatory syndrome (IRIS) remain a barrier to antiretroviral therapy (ART) initiation during antituberculosis treatment in co-infected patients...
  16. pmc A population-based and longitudinal study of sexual behavior and multidrug-resistant HIV among patients in clinical care
    Michael J Kozal
    Yale University School of Medicine, New Haven, Connecticut 06510, USA
    MedGenMed 8:72. 2006
    ..Population-based and longitudinal information regarding sexual risk behavior among patients with multidrug resistant (MDR) HIV and their sexual partners is of great public health and clinical importance...
  17. ncbi request reprint Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
    Neel R Gandhi
    AIDS Program, Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    Lancet 368:1575-80. 2006
    ..We assessed the prevalence and consequences of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in a rural area in KwaZulu Natal, South Africa...
  18. ncbi request reprint Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8
    Edana Cassol
    HIV 1 Molecular Virology and Bioinformatics Unit, Africa Centre for Health and Population Studies, and Centre for HIV AIDS Networking, Doris Duke Medical Research Institute, Durban, South Africa
    J Infect Dis 191:324-32. 2005
    ..OI-induced immune activation can interfere with HIV-1 clearance by increasing viral replication and target cell availability...
  19. pmc Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial
    Frederick L Altice
    Yale University AIDS Program, Yale University, New Haven, CT 06510 2283, USA
    Clin Infect Dis 45:770-8. 2007
    ..Directly administered antiretroviral therapy (DAART) is one approach to improve treatment adherence among human immunodeficiency virus (HIV)-infected drug users...
  20. doi request reprint Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa
    Jason R Andrews
    Yale University School of Medicine, New Haven, Connecticut 06510 2483, USA
    J Infect Dis 196:S482-90. 2007
    ..A successful response to the emergence of MDR-TB and XDR-TB will necessitate increased resources for and collaboration between TB and HIV programs...
  21. ncbi request reprint Use of total lymphocyte count for monitoring response to antiretroviral therapy
    Tanya Schreibman
    Yale University School of Medicine, AIDS Program, Yale New Haven Hospital, New Haven, Connecticut 06510, USA
    Clin Infect Dis 38:257-62. 2004
    ..The role of the TLC in the initiation of antiretroviral therapy and opportunistic infection prophylaxis, as well as the role of the TLC in monitoring the response to antiretroviral therapy, are also addressed...
  22. ncbi request reprint Attitudes toward needle-sharing and HIV transmission risk behavior among HIV+ injection drug users in clinical care
    Wynne E Norton
    Department of Psychology, University of Connecticut, Storrs, CT, USA
    AIDS Care 20:462-9. 2008
    ..Interventions targeting needle-sharing attitudes deployed within the clinical care setting may be well-positioned to reduce HIV transmission among HIV-positive IDUs...
  23. pmc Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa
    Prashini Moodley
    KwaZulu Natal Research Institute for Tuberculosis and HIV K RITH, Durban, South Africa
    PLoS ONE 6:e17513. 2011
    ..KZN is divided into 11 healthcare districts. We sought to determine the distribution of XDR TB cases in the province in relation to population density...
  24. pmc Transmission of drug-susceptible and drug-resistant tuberculosis and the critical importance of airborne infection control in the era of HIV infection and highly active antiretroviral therapy rollouts
    Sheela V Shenoi
    AIDS Program, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut 06510 2483, USA
    Clin Infect Dis 50:S231-7. 2010
    ..New research and resources are required to fully realize the potential benefits of infection control in the era of TB and HIV epidemics...
  25. ncbi request reprint Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care
    Michael J Kozal
    AIDS Program, Section of Infectious Diseases, Yale University School of Medicine and VA Connecticut Healthcare System, New Haven, Connecticut 06510, USA
    AIDS 18:2185-9. 2004
    ..However, little is known about the risk behaviors of these patients, potential partners exposed and the relationship of these to ART resistance...
  26. pmc Extensively drug-resistant tuberculosis: a new face to an old pathogen
    Sheela Shenoi
    Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut 06510 8002, USA
    Annu Rev Med 60:307-20. 2009
    ..In this article, we describe the current global status of drug-resistant tuberculosis. We discuss the development of resistance, current management, and strategies for control...
  27. pmc Antiretroviral treatment regimen outcomes among HIV-infected prisoners
    Sandra A Springer
    Yale University AIDS Program, New Haven, CT 06510 2283, USA
    HIV Clin Trials 8:205-12. 2007
    ..Despite the high prevalence of HIV in correctional settings, the duration of therapy and response to various highly active antiretroviral therapy (HAART) regimens in this setting is unknown...
  28. pmc Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study
    Sanjay Basu
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520, USA
    Lancet 370:1500-7. 2007
    ..We modelled the plausible effect of rapidly available infection control strategies on the overall course of the XDR tuberculosis epidemic in a rural area of South Africa...
  29. doi request reprint Preparing for highly active antiretroviral therapy rollout in rural South Africa: an assessment using the information, motivation, and behavioral skills model
    Margo D Simon
    AIDS Program, Yale University School of Medicine, New Haven, CT, USA
    AIDS Care 22:462-74. 2010
    ..Community-based assessments are urgently needed as HAART rollouts continue. Adaptation of this IMB-based survey may better inform efforts to enhance HAART-program implementation in resource-limited settings globally...
  30. pmc Averting epidemics of extensively drug-resistant tuberculosis
    Sanjay Basu
    Tugela Ferry Care and Research Collaboration, Tugela Ferry, KwaZulu Natal 3010, South Africa
    Proc Natl Acad Sci U S A 106:7672-7. 2009
    ....
  31. ncbi request reprint Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir
    Robert Douglas Bruce
    Department of Medicine, Yale University AIDS Program, New Haven, CT, USA
    J Acquir Immune Defic Syndr 54:511-4. 2010
    ..This study was conducted to examine the pharmacokinetic interactions between buprenorphine/naloxone (BUP/NLX) and lopinavir/ritonavir (LPV/r) in HIV-seronegative subjects chronically maintained on BUP/NLX...
  32. doi request reprint Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
    Frederick L Altice
    Department of Medicine, Section of Infectious Diseases, Yale University, New Haven, CT 06510 2283, USA
    Lancet 376:367-87. 2010
    ..Multifaceted, interdisciplinary approaches are urgently needed to achieve parity in health outcomes in HIV-infected drug users...
  33. pmc Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
    R Douglas Bruce
    Yale University AIDS Program, 135 College Street, Suite 323, New Haven, CT, United States
    Drug Alcohol Depend 105:234-9. 2009
    ..BUP/NLX and TPV/r should therefore be used cautiously to avoid decreased efficacy of TPV in patients taking these agents concomitantly...
  34. ncbi request reprint Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice
    R Douglas Bruce
    Yale University AIDS Program, 135 College Street, New Haven, CT 06511, USA
    J Acquir Immune Defic Syndr 41:563-72. 2006
    ..Global access to opioid agonist therapy and HIV treatment is expanding but when concurrently used, problematic pharmacokinetic drug interactions can occur...
  35. ncbi request reprint Opioid dependence: rationale for and efficacy of existing and new treatments
    David A Fiellin
    Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Clin Infect Dis 43:S173-7. 2006
    ..This review focuses on the neurobiological basis of opioid dependence, the rationale for methadone and buprenorphine treatments, and issues in prescribing these medications to patients with HIV infection...
  36. ncbi request reprint Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication
    Frederick L Altice
    Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut 06510 2283, USA
    Clin Infect Dis 38:S376-87. 2004
    ..Moreover, DAART should incorporate enhanced elements such as convenience, flexibility, confidentiality, cues and reminders, responsive pharmacy and medical services, and specialized training for staff...
  37. pmc Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users
    Frederick L Altice
    Yale University AIDS Program, New Haven, Connecticut 06510, USA
    J Urban Health 80:416-27. 2003
    ..In addition, it demonstrates that this population can benefit from this therapy with the support of a nontraditional, community-based health intervention...
  38. pmc Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community
    Sheela Shenoi
    Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA
    Curr Opin Infect Dis 22:11-7. 2009
    ..Physicians, researchers and policy makers must understand the myriad consequences of multidrug and extensively drug-resistant tuberculosis (TB) within the HIV community in order to guide clinical care, research and resource allocation...
  39. ncbi request reprint The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects
    Petrie M Rainey
    Yale University School of Medicine, New Haven, Conn, USA
    Am J Addict 11:66-74. 2002
    ..3 +/- 61.0 vs. 35.0 +/- 17.5 h) were detected. These results suggest that methadone dose change is not likely to be necessary for patients treated with lamivudine/zidovudine combination pharmacotherapy...
  40. ncbi request reprint Generic antiretroviral efficacy in AIDS-associated Kaposi's sarcoma in sub-Saharan Africa
    Anisa Mosam
    Department of Dermatology, Africa Centre for Health and Population Studies, Durban, South Africa
    AIDS 19:441-3. 2005
    ..At 52 weeks, 74% achieved an undetectable viral load of < 50 copies/ml, 86% achieved < 400 copies/ml, and a 3.1 log10 decline from baseline. Side-effects were minimal. The outcomes support the use of generic antiretroviral therapy...
  41. doi request reprint An inter-professional 'advocacy and activism in global health': module for the training of physician-advocates
    Michael J Peluso
    Global Health Working Group, Yale School of Medicine, USA
    Glob Health Promot 20:70-3. 2013
    ..We plan to continue to develop this program in the future, and we believe that other medical institutions should consider a similar model for introducing students to their future role as health advocates. ..
  42. ncbi request reprint Human immunodeficiency virus infection prevention: strategies for clinicians
    Tanya Schreibman
    AIDS Program, Yale School of Medicine, Yale University, Yale New Haven Hospital, New Haven, Connecticut 06437, USA
    Clin Infect Dis 36:1171-6. 2003
    ....
  43. ncbi request reprint Sexual risk behaviour among HIV-positive individuals in clinical care in urban KwaZulu-Natal, South Africa
    Susan M Kiene
    Center for Health HIV Intervention and Prevention, Department of Psychology, University of Connecticut, Storrs, CT, USA
    AIDS 20:1781-4. 2006
    ..These findings highlight the need for linking HIV prevention and care in Africa...
  44. ncbi request reprint Report from the 12th Retrovirus Conference. HIV/AIDS in resource-limited settings
    Carlos del Rio
    AIDS Clin Care 17:39-40. 2005
  45. ncbi request reprint Report from the 12th Retrovirus Conference. Adherence
    Gerald H Friedland
    AIDS Clin Care 17:36. 2005
  46. ncbi request reprint Meeting report from the XV International AIDS Conference. Adherence
    Gerald H Friedland
    AIDS Clin Care 16:74-5. 2004
  47. ncbi request reprint Meeting report from the XV International AIDS Conference. Opportunistic infections
    Gerald H Friedland
    AIDS Clin Care 16:74. 2004
  48. ncbi request reprint A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298)
    Richard B Pollard
    University of California Davis Medical Center, Patient Support Services Building, 4150 V Street, Suite G500, Sacramento, CA 95817, USA
    AIDS Res Hum Retroviruses 18:699-704. 2002
    ..Based on this study and other data, combining d4T and ZDV is not recommended...
  49. ncbi request reprint Report on the XIV International AIDS Conference
    Salim S Abdool Karim
    AIDS Clin Care 14:77-85. 2002
  50. ncbi request reprint Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Africa
    Ilene Y Wong
    Stanford Hospital and Clinics, Department of Urology, Stanford, California, USA
    J Acquir Immune Defic Syndr 43:S142-8. 2006
    ....
  51. ncbi request reprint Report from the 12th Retrovirus Conference. Tuberculosis
    Gerald H Friedland
    AIDS Clin Care 17:40-1. 2005
  52. ncbi request reprint Report from the XVI International AIDS Conference. Extensively drug-resistant TB in HIV/TB-coinfected patients in rural South Africa
    Gerald H Friedland
    AIDS Clin Care 18:102. 2006
  53. ncbi request reprint Report from the XVI International AIDS Conference. Which antiretroviral regimen first? Data from CPCRA
    Gerald H Friedland
    AIDS Clin Care 18:98-9. 2006
  54. ncbi request reprint Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial
    Sharon B Mannheimer
    Harlem Hospital and Columbia University College of Physicians and Surgeons, New York, NY 10037, USA
    J Acquir Immune Defic Syndr 43:S41-7. 2006
    ..To assess the efficacy of 2 adherence interventions, medication managers (MM) and medication alarms (ALR), among antiretroviral (ARV)-naive persons with HIV initiating ARV therapy...
  55. ncbi request reprint Report from the 13th retrovirus conference. Antiretroviral therapy in resource-limited settings
    Gerald H Friedland
    AIDS Clin Care 18:38. 2006
  56. ncbi request reprint Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study
    Robert S Broadhead
    Department of Sociology, University of Connecticut, Storrs 06269 2068, USA
    Soc Sci Med 55:235-46. 2002
    ..Innovative mechanisms that harness drug users' peer pressure to promote positive behavioral changes deserve greater study...
  57. ncbi request reprint Report from the 14th Retrovirus Conference. Antiviral therapy outcomes: large survey highlights differences and similarities worldwide
    Gerald H Friedland
    AIDS Clin Care 19:38. 2007
  58. ncbi request reprint Report from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Further exploring the findings from SMART
    Gerald H Friedland
    AIDS Clin Care 19:83. 2007
  59. ncbi request reprint Meeting notes from the 3rd IAS Conference. Treating TB and HIV concurrently
    Gerald H Friedland
    AIDS Clin Care 17:98. 2005
    ..Several IAS reports focused on strategies for overcoming reduced levels of nevirapine due to rifampin coadministration...
  60. pmc Clinic-based intervention reduces unprotected sexual behavior among HIV-infected patients in KwaZulu-Natal, South Africa: results of a pilot study
    Deborah H Cornman
    Center for Health, Intervention, and Prevention, University of Connecticut, Storrs, CT 06269, USA
    J Acquir Immune Defic Syndr 48:553-60. 2008
    ..To evaluate the feasibility, fidelity, and effectiveness of a human immunodeficiency virus (HIV) prevention intervention delivered to HIV-infected patients by counselors during routine clinical care in KwaZulu-Natal, South Africa...
  61. ncbi request reprint Meeting report from the XV International AIDS Conference. Access in the developing world
    Gerald H Friedland
    AIDS Clin Care 16:69-70. 2004
  62. ncbi request reprint AIDS: the first 25 years
    Gerald H Friedland
    AIDS Clin Care 18:53-4. 2006
  63. ncbi request reprint Meeting notes from the 3rd IAS Conference. Male circumcision: a new prevention strategy?
    Gerald H Friedland
    AIDS Clin Care 17:93-4. 2005
    ..New trial data confirm that male circumcision could substantially reduce heterosexual transmission of HIV...
  64. ncbi request reprint Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients
    Jeffrey D Fisher
    Department of Psychology, Center for Health HIV Intervention and Prevention, University of Connecticut, Storrs, CT 06269 1248, USA
    J Acquir Immune Defic Syndr 41:44-52. 2006
    ..To evaluate the effectiveness of a clinician-delivered intervention, implemented during routine clinical care, in reducing unprotected sexual behavior of HIV-infected patients...

Research Grants4

  1. NEW ENGLAND PROGRAM FOR AIDS CLINICAL TRIALS-PROACT (CPC
    Gerald Friedland; Fiscal Year: 2006
    ..Among the three ProACT sites we will enroll and follow 200 patients on study protocols at any given time over the course of this grant. ..
  2. Drug Interactions in Substance Abusers with HIV Infection
    Gerald Friedland; Fiscal Year: 2009
    ..This grant will perform studies to identify these interactions and improve the treatment of these conditions in this vulnerable population. ..
  3. Drug Interactions in Substance Abusers with HIV Infection
    Gerald H Friedland; Fiscal Year: 2010
    ..This grant will perform studies to identify these interactions and improve the treatment of these conditions in this vulnerable population. ..